Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Testing IDs Actionable Drivers in Up to Two-Thirds of Lung Cancers
Patients receiving targeted drugs based on molecular drivers lived longer
This article is older than one year and is no longer available.

Copyright © 2014 HealthDay. All rights reserved.

April 30, 2016

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA Reconsidering Training for Doctors Prescribing Opioids

Costs for Orally Administered Cancer Drugs Up Since 2000

First Zika-Related Death in Puerto Rico Reported

First Commercial Zika Test Approved by FDA

Wide Variation in Health Care Costs Across the U.S.

Picture-Guided Cards Can Help Chaplains Provide Spiritual Care